本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Bausch Health Companies Inc

5.30
+0.0000
盤後5.22-0.0800-1.51%16:09 EDT
成交量:316.94萬
成交額:1,654.59萬
市值:19.58億
市盈率:-42.40
高:5.34
開:5.20
低:5.00
收:5.30
資料載入中...

公司資料

公司名字:
Bausch Health Companies Inc
交易所:
NYSE
成立時間:
- -
員工人數:
20700
公司地址:
2150 St. ElzEar Boulevard West,Laval,Quebec,Canada
郵編:
H7L 4A8
電話:
傳真:
- -
簡介:
Bausch Health Companies Inc.是一家在加拿大不列顛哥倫比亞省註冊的公司。該公司是一家跨國、專業製藥和醫療器械公司,主要在胃腸病學和皮膚病學的治療領域開發、製造和銷售一系列廣泛的品牌、非專利和品牌非專利藥品、非處方藥產品和醫療美容器械,並通過其對Bausch + Lomb Corporation約89%的所有權,在眼健康治療領域開發品牌和品牌非專利藥品、非處方藥產品和醫療器械(隱形眼鏡、人工晶狀體、眼科手術設備)。該公司的產品直接或間接銷往大約100個國家。

董事

名稱
職位
Joseph C. Papa
Director, Chairman of the Board and Chief Executive Officer
Amy B. Wechsler
Independent Director
Andrew C. von Eschenbach
Independent Director
Argeris N. Karabelas
Independent Director
Brett M. Icahn
Independent Director
John A. Paulson
Independent Director
Richard U. De Schutter
Independent Director
Robert Hale
Independent Director
Robert N. Power
Independent Director
Russel C. Robertson
Independent Director
Sarah B. Kavanagh
Independent Director
Steven D. Miller
Independent Director
Thomas W. Ross, Sr.
Independent Director

股東

名稱
職位
Joseph C. Papa
Director, Chairman of the Board and Chief Executive Officer
Paul S. Herendeen
Executive Vice President and Chief Financial Officer
Christina M. Ackermann
Executive Vice President, General Counsel and Head of Commercial Operations
Joseph F. Gordon
President & Co-Head Bausch + Lomb/International
Robert A. Spurr
President, Salix
Thomas J. Appio
President & Co-Head Bausch + Lomb/International